A little-known biotech working on a COVID-19 vaccine has surged 304% in just 2 days — and it just said it was picked for the US government's 'Operation Warp Speed' program (VXRT)

A little-known biotech working on a COVID-19 vaccine has surged 304% in just 2 days — and it just said it was picked for the US government's 'Operation Warp Speed' program (VXRT)

Business Insider

Published

· *Vaxart, a small-cap biotechnology company that is focused on developing oral vaccines administered by tablet rather than injection, said on Friday that it has been selected for the US Government's Operation Warp Speed project.*
· *Vaxart's stock has skyrocketed as much as 449% this week after releasing a slew of news...

Full Article